Detalhe da pesquisa
1.
Small Cell Carcinoma of the Vagina: First Systematic Review of Case Reports and Proposal of a Management Algorithm.
J Low Genit Tract Dis
; 27(1): 56-67, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36282979
2.
Hypoxia: The Cornerstone of Glioblastoma.
Int J Mol Sci
; 22(22)2021 Nov 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34830491
3.
Small-Cell Lung Cancer Long-Term Survivor Patients: How to Find a Needle in a Haystack?
Int J Mol Sci
; 22(24)2021 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34948300
4.
The C250T Mutation of TERTp Might Grant a Better Prognosis to Glioblastoma by Exerting Less Biological Effect on Telomeres and Chromosomes Than the C228T Mutation.
Cancers (Basel)
; 16(4)2024 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38398126
5.
The S-REAL study: Spanish real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy.
Clin Transl Oncol
; 2024 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38512450
6.
Recurrent Glioblastoma: Ongoing Clinical Challenges and Future Prospects.
Onco Targets Ther
; 16: 71-86, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36721854
7.
Characterization of a cohort of metastatic lung cancer patients harboring KRAS mutations treated with immunotherapy: differences according to KRAS G12C vs. non-G12C.
Front Oncol
; 13: 1239000, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37916173
8.
Preoperative Diagnosis and Molecular Characterization of Gliomas With Liquid Biopsy and Radiogenomics.
Front Neurol
; 13: 865171, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35693015
9.
Biological and clinical perspectives of the actionable gene fusions and amplifications involving tyrosine kinase receptors in lung cancer.
Cancer Treat Rev
; 109: 102430, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35777135
10.
In silico validation of RNA-Seq results can identify gene fusions with oncogenic potential in glioblastoma.
Sci Rep
; 12(1): 14439, 2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36002559
11.
Glioblastoma: Relationship between Metabolism and Immunosuppressive Microenvironment.
Cells
; 10(12)2021 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34944036
12.
Immune-checkpoint inhibitors for lung cancer patients amid the COVID-19 pandemic: a case report of severe meningoencephalitis after switching to an extended-interval higher flat-dose nivolumab regimen.
Transl Lung Cancer Res
; 10(4): 1917-1923, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34012801
13.
Correlation between PD-L1 expression and MET gene amplification in patients with advanced non-small cell lung cancer and no other actionable oncogenic driver.
Oncotarget
; 12(18): 1802-1810, 2021 Aug 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34504652
14.
Perilesional edema in brain metastases as predictive factor of response to systemic therapy in non-small cell lung cancer patients: a preliminary study.
Ann Transl Med
; 9(8): 648, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33987346
15.
Characteristics of Adrenocortical Carcinoma Associated With Lynch Syndrome.
J Clin Endocrinol Metab
; 106(2): 318-325, 2021 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33185660
16.
Randomised phase 2 study comparing the efficacy and safety of the oral tyrosine kinase inhibitor nintedanib with single agent ifosfamide in patients with advanced, inoperable, metastatic soft tissue sarcoma after failure of first-line chemotherapy: EORTC-1506-STBSG "ANITA".
Eur J Cancer
; 152: 26-40, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34062484
17.
Epidemiology, treatment, and survival in small cell lung cancer in Spain: Data from the Thoracic Tumor Registry.
PLoS One
; 16(6): e0251761, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34077442
18.
RNA sequencing and Immunohistochemistry Reveal ZFN7 as a Stronger Marker of Survival than Molecular Subtypes in G-CIMP-negative Glioblastoma.
Clin Cancer Res
; 27(2): 645-655, 2021 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33106291
19.
Endocrine adverse events related to immune-oncology agents: retrospective experience of a single institution.
Transl Lung Cancer Res
; 9(1): 103-110, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32206558
20.
A phase II randomized, multicenter, open-label trial of continuing adjuvant temozolomide beyond 6 cycles in patients with glioblastoma (GEINO 14-01).
Neuro Oncol
; 22(12): 1851-1861, 2020 12 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32328662